Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

VKTX - Viking Therapeutics, Inc. Financial... | Finranks

Home

/

VKTX

V

Viking Therapeutics, Inc. (VKTX)

NCM – Real Time Price. Currency in USD

34.49

+0.69 (2.04%)

Market open: Aug 12, 2026, 12:41 PM EDT

33.86

+0.06 (0.18%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-431K

-346K

-292K

-291K

Gross Profit

-431K

-346K

-292K

-291K

Operating expenses (excl. COGS)

-393M

-151M

-101M

-70M

Operating Income

-393M

-151M

-101M

-70M

Non-operating income, total

34M

41M

15M

1M

Pretax income

-360M

-110M

-86M

-69M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-360M

-110M

-86M

-69M

Discontinued operations

0

0

0

0

Net income

-360M

-110M

-86M

-69M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

716M-21.2%

908M+146.5%

368M+118.7%

169M

Total current assets

716M

907M

367M

167M

Total non-current assets

131K

1M

1M

1M

Total liabilities

77M+173.4%

28M+39.7%

20M-13.5%

23M

Total current liabilities

77M

27M

19M

22M

Total non-current liabilities

0

630K

936K

1M

Total equity

639M

880M

348M

145M

Total liabilities & shareholders' equities

716M

908M

368M

169M

Total debt

137K-87.8%

1M-11.2%

1M-19.4%

2M

Name

2025

2024

2023

2022

Cash from operating activities

-279M

-88M

-73M

-48M

Cash from investing activities

341M

-553M

-179M

55M

Cash from financing activities

76M

612M

271M

4M

Free cash flow

-279M-217.4%

-88M-19.6%

-73M-51.6%

-48M